Epivax Oncology
Providence
About Epivax Oncology
EpiVax Oncology is a provider of a clinical research and development platform intended to offer various type of precision cancer immunotherapies. The company's platform are based on optimal neo-epitopes selected through its proprietary and validated, in-silico, predictive algorithms, enabling clients to address the unmet medical needs that are inadequately addressed by current cancer therapeutic approaches.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Last round: Series Unknown (Jun 2018)
- Website: epivaxtx.com
Industries & Categories
Biotechnology, Health Care, Hospital, Oncology
Social Profiles
Canonical: https://fsome.com/organization/epivax-oncology-119646 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.